Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.
SYMBOL - BCL.P
VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ - Beanstalk Capital Ltd.
("Beanstalk") is pleased to announce that it has entered into an arm's
length arrangement agreement dated October 15, 2007 (the "Arrangement
Agreement") with iCo
Therapeutics Inc. ("i...
Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
CARLSBAD, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Isis
Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced that it has received a
$1.25 million milestone payment in the form of equity securities in iCo
Therapeutics. The milestone was related to the initiation of Phase 1
clinical trials of ...
Dr. Daniel Ronel Offers New Permanent Lip Enhancement in New Mexico
One of the most popular aesthetic procedures is lip enhancement. 'The lips are the first thing that most people notice about women' explains Dr. Daniel Ronel, a board certified plastic surgeon in Albuquerque and Santa Fe New Mexico.
(Vocus) May 21, 2009 -- One of the mo...
Catholic Charities Executive to Speak at Caritas Internationalis
...of Catholic Charities USA, in Alexandria, Virginia, will participate in an interactive dialogue-briefing on Monday, June 15th at 3:00-4:30 p.m. at the ico
CENTER, located on East 47th Street, between First & Second Avenue, above Holy Family Church, in New York City.
International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
... SCOTT DEPOT, W.Va., April 30 /PRNewswire-FirstCall/ -- International Coal Group, Inc. (NYSE: ico
) is proud to announce that it is the lead Pink Ribbon sponsor for the 2009 Susan G. Komen Race For The Cure on Saturday, May 2. The 5-kilometer race/...
Cash-strapped Optometry Students Give Back in a Big Way
...dize the cost and support the humanitarian work of ico
"When you think about it, ...racticing optometrists."
This weekend, 25 ico
students will depart for Honduras, the last of nin...ividuals less fortunate and we are proud to assist ico
with these services."
Editor's Note: Imag...
Isis Reports Financial Results and Highlights for Fiscal year 2007
...s an antisense drug discovered by Isis and licensed to ATL and is currently in Phase 2 studies for the treatment of multiple sclerosis. * ico
initiated Phase 1 studies of iCo-007, an antisense drug discovered by Isis for the treatment of various eye diseases. Isis received a $1.25...